These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 15329030)

  • 1. Varicella vaccination in Italy : an economic evaluation of different scenarios.
    Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
    Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy.
    Holl K; Sauboin C; Amodio E; Bonanni P; Gabutti G
    BMC Public Health; 2016 Oct; 16(1):1103. PubMed ID: 27769206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic value of childhood varicella vaccination in France and Germany.
    Coudeville L; Brunot A; Szucs TD; Dervaux B
    Value Health; 2005; 8(3):209-22. PubMed ID: 15877593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of varicella vaccination in Spain: results from a dynamic model.
    Lenne X; Diez Domingo J; Gil A; Ridao M; Lluch JA; Dervaux B
    Vaccine; 2006 Nov; 24(47-48):6980-9. PubMed ID: 16860909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases.
    Bonanni P; Boccalini S; Bechini A; Banz K
    Vaccine; 2008 Oct; 26(44):5619-26. PubMed ID: 18723062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of a routine varicella vaccination program for US children.
    Lieu TA; Cochi SL; Black SB; Halloran ME; Shinefield HR; Holmes SJ; Wharton M; Washington AE
    JAMA; 1994 Feb; 271(5):375-81. PubMed ID: 8283587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
    Wutzler P; Neiss A; Banz K; Goertz A; Bisanz H
    Med Microbiol Immunol; 2002 Oct; 191(2):89-96. PubMed ID: 12410347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster.
    Littlewood KJ; Ouwens MJ; Sauboin C; Tehard B; Alain S; Denis F
    Clin Ther; 2015 Apr; 37(4):830-841.e7. PubMed ID: 25721380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An economic evaluation and incremental analysis of the cost effectiveness of three universal childhood varicella vaccination strategies for Ireland.
    Ahern S; Browne J; Murphy A; Teljeur C; Ryan M
    Vaccine; 2024 May; 42(14):3321-3332. PubMed ID: 38609807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An economic evaluation of varicella vaccination in Italian adolescents.
    Thiry N; Beutels P; Tancredi F; Romanò L; Zanetti A; Bonanni P; Gabutti G; Van Damme P
    Vaccine; 2004 Sep; 22(27-28):3546-62. PubMed ID: 15315834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.
    Scuffham P; Devlin N; Eberhart-Phillips J; Wilson-Salt R
    Soc Sci Med; 1999 Sep; 49(6):763-79. PubMed ID: 10459888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of varicella vaccination in Canada.
    Brisson M; Edmunds WJ
    Vaccine; 2002 Jan; 20(7-8):1113-25. PubMed ID: 11803072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of routine childhood varicella vaccination in Germany.
    Banz K; Wagenpfeil S; Neiss A; Goertz A; Staginnus U; Vollmar J; Wutzler P
    Vaccine; 2003 Mar; 21(11-12):1256-67. PubMed ID: 12559807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-benefit analysis of routine childhood vaccination against chickenpox in Taiwan: decision from different perspectives.
    Hsu HC; Lin RS; Tung TH; Chen TH
    Vaccine; 2003 Sep; 21(25-26):3982-7. PubMed ID: 12922134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Impact and Cost-effectiveness Assessment for the Introduction of Universal Varicella Vaccination in Switzerland.
    Heininger U; Pillsbury M; Samant S; Lienert F; Guggisberg P; Gani R; O'Brien E; Pawaskar M
    Pediatr Infect Dis J; 2021 Jun; 40(6):e217-e221. PubMed ID: 33872276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An economic analysis of the universal varicella vaccination program in the United States.
    Zhou F; Ortega-Sanchez IR; Guris D; Shefer A; Lieu T; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S156-64. PubMed ID: 18419391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study.
    Melegaro A; Marziano V; Del Fava E; Poletti P; Tirani M; Rizzo C; Merler S
    BMC Med; 2018 Jul; 16(1):117. PubMed ID: 30012132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.
    Valentim J; Sartori AM; de Soárez PC; Amaku M; Azevedo RS; Novaes HM
    Vaccine; 2008 Nov; 26(49):6281-91. PubMed ID: 18674582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What We Know Now: An Economic Evaluation of Chickenpox Vaccination and Dose Timing Using an Agent-Based Model.
    Rafferty ERS; McDonald W; Osgood ND; Doroshenko A; Farag M
    Value Health; 2021 Jan; 24(1):50-60. PubMed ID: 33431153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.